Oneness Biotech Co Ltd (4743):企業の財務・戦略的SWOT分析

◆英語タイトル:Oneness Biotech Co Ltd (4743) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH237316FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oneness Biotech Co Ltd (Oneness Biotech) is a bio pharmaceutical company that conducts research and development of drugs. The company provides products such as anti acne products. Its technologies comprise GAP cultivation platform, medicinal material identification, and separation and purification platform, among others. Oneness Biotech provides botanical medicinal material identification platform such as taxonomy, geography, physical and chemical identification, powder identification, DNA molecular identification, and others. The company’s GAP cultivation platform utilizes the quality and efficacy technique in ecological environmental study and nursing and standardized cultivation. Its products are used for the treatment of liver cancer, prostate cancer, lung cancer and non-proliferation of estrogen-dependent breast cancer. Oneness Biotech is headquartered in Taipei, Taiwan.

Oneness Biotech Co Ltd Key Recent Developments

Mar 15,2021: Significant news ─ Announcement The company has received a notice from Zhongtian (Shanghai) Biotechnology Co., Ltd. This afternoon, it received a written notice from the Center for Drug Evaluation (CDE) of the China National Medical Products Administration to officially accept ON101, a new drug for diabetic foot wound ulcers. Mainland China Pharmaceutical product registration application (NDA)

This comprehensive SWOT profile of Oneness Biotech Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Oneness Biotech Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Oneness Biotech Co Ltd – Key Information
Oneness Biotech Co Ltd – Overview
Oneness Biotech Co Ltd – Key Employees
Oneness Biotech Co Ltd – Key Employee Biographies
Oneness Biotech Co Ltd – Key Operational Heads
Oneness Biotech Co Ltd – Major Products and Services
Oneness Biotech Co Ltd – History
Oneness Biotech Co Ltd – Company Statement
Oneness Biotech Co Ltd – Locations And Subsidiaries
Oneness Biotech Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Oneness Biotech Co Ltd – Business Description
Oneness Biotech Co Ltd – Corporate Strategy
Oneness Biotech Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Oneness Biotech Co Ltd – Strengths
Oneness Biotech Co Ltd – Weaknesses
Oneness Biotech Co Ltd – Opportunities
Oneness Biotech Co Ltd – Threats
Oneness Biotech Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Oneness Biotech Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Oneness Biotech Co Ltd, Key Information
Oneness Biotech Co Ltd, Key Ratios
Oneness Biotech Co Ltd, Share Data
Oneness Biotech Co Ltd, Major Products and Services
Oneness Biotech Co Ltd, History
Oneness Biotech Co Ltd, Key Employees
Oneness Biotech Co Ltd, Key Employee Biographies
Oneness Biotech Co Ltd, Key Operational Heads
Oneness Biotech Co Ltd, Other Locations
Oneness Biotech Co Ltd, Subsidiaries
Oneness Biotech Co Ltd, Key Competitors
Oneness Biotech Co Ltd, SWOT Analysis
Oneness Biotech Co Ltd, Ratios based on current share price
Oneness Biotech Co Ltd, Annual Ratios
Oneness Biotech Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Oneness Biotech Co Ltd (4743):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Innospec Inc. (IOSP):石油・ガス:M&Aディール及び事業提携情報
    Summary Innospec Inc (Innospec) is a provider of specialty chemicals. It blends, manufactures and supplies fuel additives and other specialty chemicals. Innospec’s product portfolio includes stabilizers, detergents, cold flow improvers, lubricity improvers, corrosion inhibitors, conductivity improve …
  • Distell Group Limited:戦略・SWOT・企業財務分析
    Distell Group Limited - Strategy, SWOT and Corporate Finance Report Summary Distell Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • H. Lundbeck A/S:企業の戦略・SWOT・財務情報
    H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report Summary H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Reinsurance Group of America, Incorporated:戦略・SWOT・企業財務分析
    Reinsurance Group of America, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Reinsurance Group of America, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Aerostar S.A.:企業の戦略・SWOT・財務情報
    Aerostar S.A. - Strategy, SWOT and Corporate Finance Report Summary Aerostar S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Southern Company Gas:石油・ガス:M&Aディール及び事業提携情報
    Summary Southern Company Gas (SCG), formerly AGL Resources Inc., is an energy services holding company It operates through natural gas distribution, retail operations, wholesale services and midstream. The company serves utility customers through its regulated distribution subsidiaries in the states …
  • Supernus Pharmaceuticals Inc (SUPN)-製薬・医療分野:企業M&A・提携分析
    Summary Supernus Pharmaceuticals Inc (Supernus) is a specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company's neurology portfolio consists of Oxtellar XR (oxcarbazepine), an adjunct therapy for the treatment …
  • Landmark Graphics Corp:企業の戦略的SWOT分析
    Landmark Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Mitsubishi Gas Chemical Co Inc (4182):製薬・医療:M&Aディール及び事業提携情報
    Summary Mitsubishi Gas Chemical Co Inc (MGC) is a chemicals company. It provides various products in a wide range of fields from basic chemicals to fine chemicals and functional materials. The company produces and sells xylene isomers, xylene derivatives and foaming plastics; inorganic chemicals and …
  • London North West Healthcare NHS Trust:企業の戦略的SWOT分析
    London North West Healthcare NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Interconexion Electrica SA ESP (ISA):企業の財務・戦略的SWOT分析
    Interconexion Electrica SA ESP (ISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Linn Energy Inc (LNGG):石油・ガス:M&Aディール及び事業提携情報
    Summary Linn Energy Inc (Linn Energy), formerly Linn Energy LLC, is an independent energy company. It explores for, develops, and produces oil, natural gas, and natural gas liquids (NGLs). The company has upstream assets in various operating regions in the US such as Hugoton Basin, the Mid-Continent …
  • Dompe Farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Dompe Farmaceutici SpA (Dompe) is a developer of therapeutic solutions that research novel therapies for the treatment of rare and orphan diseases. The company provides product pipeline such as C5aR Antagonists, TRPM8 Blockers pain, TRPM8 Blockers urology, BKB1R Antagonists, CNR2 Agonists an …
  • Asia Paper Manufacturing Co., Ltd.:企業の戦略・SWOT・財務情報
    Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Saipem SpA:企業の戦略・SWOT・財務情報
    Saipem SpA - Strategy, SWOT and Corporate Finance Report Summary Saipem SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Hensel Phelps Construction Co:企業の戦略的SWOT分析
    Hensel Phelps Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Moog Inc.:企業のM&A・事業提携・投資動向
    Moog Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moog Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Endonovo Therapeutics Inc (ENDV):企業の製品パイプライン分析2018
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • UNIQA Serbia:企業の戦略・SWOT・財務情報
    UNIQA Serbia - Strategy, SWOT and Corporate Finance Report Summary UNIQA Serbia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • NextCare Holdings Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NextCare Holdings Inc (NextCare) is a healthcare service provider that offer urgent care services, walk-ins medical clinics, general medical care and occupational medicine. The center’s urgent care services include DOT physicals, illness treatment, minor injury care, pediatrics, X-rays, immu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆